My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 146

    1.

    Awareness and treatment of dyslipidemia in young adults with type 1 diabetes.

    Wadwa RP, Kinney GL, Maahs DM, Snell-Bergeon J, Hokanson JE, Garg SK, Eckel RH, Rewers M.

    Diabetes Care. 2005 May;28(5):1051-6.PMID: 15855566 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population.

    Maahs DM, Kinney GL, Wadwa P, Snell-Bergeon JK, Dabelea D, Hokanson J, Ehrlich J, Garg S, Eckel RH, Rewers MJ.

    Diabetes Care. 2005 Feb;28(2):301-6.PMID: 15677783 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Cardiac risk factors in polio survivors.

    Gawne AC, Wells KR, Wilson KS.

    Arch Phys Med Rehabil. 2003 May;84(5):694-6.PMID: 12736884 [PubMed - indexed for MEDLINE]Related articles

    4.

    Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study.

    O'Meara JG, Kardia SL, Armon JJ, Brown CA, Boerwinkle E, Turner ST.

    Arch Intern Med. 2004 Jun 28;164(12):1313-8.PMID: 15226165 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Prevalence of dyslipidemia and general ineffectiveness of its treatment in both primary and secondary prevention of coronary heart disease within family medicine framework--results of LIPIDOGRAM 2005--a nationwide epidemiological study. Dyslipidemia in Poland--ineffective treatment.

    Konduracka E, Jóźwiak J, Mastej M, Lukas W, Tykarski A, Szczepaniak-Chicheł L, Piwowarska W.

    Przegl Lek. 2008;65(12):834-7.PMID: 19441674 [PubMed - indexed for MEDLINE]Related articles

    6.

    Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium.

    Goff DC Jr, Bertoni AG, Kramer H, Bonds D, Blumenthal RS, Tsai MY, Psaty BM.

    Circulation. 2006 Feb 7;113(5):647-56.PMID: 16461837 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Prevalence and treatment of dyslipidemia in Canadian primary care: a retrospective cohort analysis.

    Petrella RJ, Merikle E, Jones J.

    Clin Ther. 2007 Apr;29(4):742-50.PMID: 17617298 [PubMed - indexed for MEDLINE]Related articles

    8.

    Awareness of hypertension and dyslipidemia in a semirural population of young adults: the Bogalusa Heart Study.

    Frontini MG, Srinivasan SR, Elkasabany A, Berenson GS.

    Prev Med. 2003 Apr;36(4):398-402.PMID: 12649047 [PubMed - indexed for MEDLINE]Related articles

    9.

    The control of dyslipidemia in outpatient clinics in Greece (OLYMPIC) Study.

    Diamantopoulos EJ, Athyros VG, Yfanti GK, Migdalis EN, Elisaf M, Vardas PE, Manolis AS, Karamitsos DT, Ganotakis ES, Hatseras D; OLYMPIC Study Group.

    Angiology. 2005 Nov-Dec;56(6):731-41.PMID: 16327950 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres.

    González-Clemente JM, Piniés JA, Calle-Pascual A, Saavedra A, Sánchez C, Bellido D, Martín-Folgueras T, Moraga I, Recasens A, Girbés J, Sánchez-Zamorano MA, Mauricio D; PADiD Study Group.

    Diabet Med. 2008 Apr;25(4):427-34. Epub 2008 Mar 13.PMID: 18341592 [PubMed - indexed for MEDLINE]Related articles

    11.

    Prevalence of conventional risk factors in Jordanians with coronary heart disease: the Jordan Hyperlipidemia and Related Targets Study (JoHARTS).

    Hammoudeh AJ, Al-Tarawneh H, Elharassis A, Haddad J, Mahadeen Z, Badran N, Izraiq M, Al-Mousa E.

    Int J Cardiol. 2006 Jun 16;110(2):179-83. Epub 2005 Oct 17.PMID: 16233922 [PubMed - indexed for MEDLINE]Related articles

    12.

    The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.

    Tong PC, Kong AP, So WY, Yang X, Ho CS, Ma RC, Ozaki R, Chow CC, Lam CW, Chan JC, Cockram CS.

    Diabetes Care. 2007 May;30(5):1206-11. Epub 2007 Jan 26.PMID: 17259472 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Statins and diabetes.

    Carmena R, Betteridge DJ.

    Semin Vasc Med. 2004 Nov;4(4):321-32. Review.PMID: 15861314 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.

    Fox KM, Gandhi SK, Ohsfeldt RL, Blasetto JW, Bays HE.

    Curr Med Res Opin. 2007 Sep;23(9):2125-33.PMID: 17655813 [PubMed - indexed for MEDLINE]Related articles

    15.

    Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.

    Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A.

    Diabetes Care. 2007 Jan;30(1):113-9. Erratum in: Diabetes Care. 2007 Feb;30(2):455. PMID: 17192343 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Evaluating the benefits of treating dyslipidemia: the importance of diabetes as a risk factor.

    Grover SA, Coupal L, Zowall H, Weiss TW, Alexander CM.

    Am J Med. 2003 Aug 1;115(2):122-8.PMID: 12893398 [PubMed - indexed for MEDLINE]Related articles

    17.

    Dyslipidemia and the treatment of lipid disorders in African Americans.

    Taylor HA Jr, Akylbekova EL, Garrison RJ, Sarpong D, Joe J, Walker E, Wyatt SB, Steffes MW.

    Am J Med. 2009 May;122(5):454-63.PMID: 19375555 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.

    Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.

    Am J Geriatr Pharmacother. 2005 Dec;3(4):218-28.PMID: 16503317 [PubMed - indexed for MEDLINE]Related articles

    19.

    Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome.

    Esteghamati A, Abbasi M, Nakhjavani M, Yousefizadeh A, Basa AP, Afshar H.

    Cardiovasc Diabetol. 2006 Jul 17;5:15.PMID: 16842631 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV).

    Schwab KO, Doerfer J, Hecker W, Grulich-Henn J, Wiemann D, Kordonouri O, Beyer P, Holl RW; DPV Initiative of the German Working Group for Pediatric Diabetology.

    Diabetes Care. 2006 Feb;29(2):218-25.PMID: 16443863 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity